C Hansen, P Müller, F Seibt, H Oesterwitz, G May, V Strobelt, J Kaden, G Ditscherlein, D Scholz
{"title":"【OKT-3在肾移植后排斥反应中的应用】。","authors":"C Hansen, P Müller, F Seibt, H Oesterwitz, G May, V Strobelt, J Kaden, G Ditscherlein, D Scholz","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Application of OKT-3 as rescue therapy in steroid-resistant rejection was effective in 7 out of 9 patients early after cadaveric kidney transplantation. Under attention of instructions for use of OKT-3 the adverse first-dose reactions are rare. The problem of OKT-3 therapy is early use and its reuse.</p>","PeriodicalId":76863,"journal":{"name":"Zeitschrift fur Urologie und Nephrologie","volume":"83 4","pages":"165-70"},"PeriodicalIF":0.0000,"publicationDate":"1990-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Use of OKT-3 in treatment of rejection following kidney transplantation].\",\"authors\":\"C Hansen, P Müller, F Seibt, H Oesterwitz, G May, V Strobelt, J Kaden, G Ditscherlein, D Scholz\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Application of OKT-3 as rescue therapy in steroid-resistant rejection was effective in 7 out of 9 patients early after cadaveric kidney transplantation. Under attention of instructions for use of OKT-3 the adverse first-dose reactions are rare. The problem of OKT-3 therapy is early use and its reuse.</p>\",\"PeriodicalId\":76863,\"journal\":{\"name\":\"Zeitschrift fur Urologie und Nephrologie\",\"volume\":\"83 4\",\"pages\":\"165-70\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1990-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Zeitschrift fur Urologie und Nephrologie\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Zeitschrift fur Urologie und Nephrologie","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
[Use of OKT-3 in treatment of rejection following kidney transplantation].
Application of OKT-3 as rescue therapy in steroid-resistant rejection was effective in 7 out of 9 patients early after cadaveric kidney transplantation. Under attention of instructions for use of OKT-3 the adverse first-dose reactions are rare. The problem of OKT-3 therapy is early use and its reuse.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
